ArticleFrontiers in pediatrics2020
Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- Treatment Outcomes and Prognostic Factors in Children with Myeloid Leukemia Associated with Down Syndrome: A Nationwide Polish Retrospective Study.Journal of clinical medicine · 2026Article
- Outcomes of down syndrome-related myeloid leukemia in Turkiye: a multicenter retrospective observational cohort study by the Turkish Pediatric Hematology Association.Annals of hematology · 2026Observational
- Article
- Acute leukaemia in children with Down syndrome in a low middle-income country.Ecancermedicalscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 14 institutions in 1 country.
Malgorzata CzogalaDepartment of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
Katarzyna Pawinska-WasikowskaDepartment of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
Teofila KsiazekDepartment of Pediatric Oncology and Hematology, University Children Hospital, Kraków, Poland.
Barbara Sikorska-FicDepartment of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland.
Michal MatysiakDepartment of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland.
Jolanta Skalska-SadowskaDepartment of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznań, Poland.
Jacek WachowiakDepartment of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznań, Poland.
Anna Rodziewicz-KonarskaDepartment of Bone Marrow Transplantation, Pediatric Oncology and Hematology, Medical University of Wroclaw, Wrocław, Poland.
Alicja ChybickaDepartment of Bone Marrow Transplantation, Pediatric Oncology and Hematology, Medical University of Wroclaw, Wrocław, Poland.
Katarzyna Myszynska-RoslanDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland.
Maryna Krawczuk-RybakDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland.
Dominik GrabowskiDepartment of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.
Jerzy KowalczykDepartment of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.
Lucyna Maciejka-KemblowskaDepartment of Pediatrics, Hematology and Oncology, University Medical Centre, Gdańsk, Poland.
Elzbieta Adamkiewicz-DrozynskaDepartment of Pediatrics, Hematology and Oncology, University Medical Centre, Gdańsk, Poland.
Katarzyna BobeffDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Łódź, Poland.
Wojciech MlynarskiDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Łódź, Poland.
Renata TomaszewskaDepartment of Pediatrics Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
Tomasz SzczepanskiDepartment of Pediatrics Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
Joanna PohoreckaPaediatric Department of Hematology and Oncology, Regional Polyclinic Hospital in Kielce, Kielce, Poland.
Agnieszka Chodala-GrzywaczPaediatric Department of Hematology and Oncology, Regional Polyclinic Hospital in Kielce, Kielce, Poland.
Grazyna KarolczykPaediatric Department of Hematology and Oncology, Regional Polyclinic Hospital in Kielce, Kielce, Poland.
Agnieszka Mizia-MalarzDepartment of Oncology, Hematology and Chemotherapy, John Paul II Upper Silesian Child Heath Centre, The Independent Public Clinical Hospital No. 6 of the Medical University of Silesia in Katowice, Katowice, Poland.
Katarzyna MyckoDepartment of Pediatrics and Hematology and Oncology, Province Children's Hospital, Olsztyn, Poland.
Wanda BadowskaDepartment of Pediatrics and Hematology and Oncology, Province Children's Hospital, Olsztyn, Poland.
Karolina ZielezinskaDepartment of Pediatrics, Hematology and Oncology, Pomeranian Medical University, Szczecin, Poland.
Tomasz UrasinskiDepartment of Pediatrics, Hematology and Oncology, Pomeranian Medical University, Szczecin, Poland.
Magdalena NykielDepartment of Pediatrics, Hematology and Oncology, City Hospital, Chorzów, Poland.
Mariola WoszczykDepartment of Pediatrics, Hematology and Oncology, City Hospital, Chorzów, Poland.
Malgorzata CiebieraDepartment of Pediatric Oncohematology, Clinical Province Hospital of Rzeszów, Rzeszow, Poland.
Radosław ChaberDepartment of Pediatric Oncohematology, Clinical Province Hospital of Rzeszów, Rzeszow, Poland.
Szymon SkoczenDepartment of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
Walentyna BalwierzDepartment of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
Jagiellonian University · PLKielce University of Technology · PLMedical University of Silesia · PLMedical University of Białystok · PLMedical University of Lodz · PLMedical University of Lublin · PLMedical University of Warsaw · PLPomeranian Medical University · PLPoznan University of Medical Sciences · PLRzeszów University · PLUniversity Clinical Centre · PLUniversity of Computer Sciences and Economics in Olsztyn · PLUniversity of Wrocław · PLWroclaw Medical University · PL
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
childrendown syndromegenetic characteristicsmyeloid leukemiatreatment results
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.